The Hill (3/5, Choi) reports, “A poll published Thursday found that Americans have lost trust in federal health institutions and are more likely to say they trust independent, professional medical organizations when it comes to advice on topics like vaccination.” The survey by the Annenberg Public Policy Center “found that public trust in agencies like the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) had fallen by 5 to 7 percentage points in the past year.”
The Washington Post (3/5, Sun) also reports, “At the same time, Americans say they have greater confidence in major professional health associations to provide more trustworthy public health information than the federal health agencies.” Survey results show “73% are confident in the American Medical Association to provide trustworthy information related to public health.”

Related Links:

— “Trust in CDC, FDA, NIH shrinks: Survey,”Joseph Choi, The Hill, March 5, 2026

USA Today (3/5, Loehrke) reports the one-hour change amid the transition into daylight saving time “may have an effect on our circadian rhythms, which are the body’s natural 24-hour cycles that regulate essential processes like eating, mood and sleep.” According to USA Today, “the reversal of our biological clocks has been connected to a higher risk of heart attacks, cancer, depression and obesity.” Notably, “the transition from winter to spring can set off mental health problems for many people. About 10% of people” with seasonal affective disorder “have the condition in the spring and summer months.” Additionally, “going to bed later or waking up earlier than usual during the first few days of the time shift could result in sleep deprivation.”

Related Links:

— “For some, the ‘spring forward’ has a cost to their mental health,”Janet Loehrke , USA Today, March 5, 2026

HealthDay (3/5, Neff) reports a study found that “as cannabis use becomes more common and weed more potent, the link between the drug and serious mood disorders is intensifying.” The researchers “analyzed data collected from 35,000 Canadians age 15 and older who were surveyed between 2012 to 2022. This timeframe captures the period before and after Canada legalized recreational cannabis in 2018.” The study “highlights a troubling trend: Cannabis use and mental health struggles are increasingly appearing together. While the study does not definitively prove that one causes the other, the statistical overlap is hard to ignore.” For example, researchers noted that “reports of generalized anxiety disorder and major depression nearly doubled, affecting 5.2% and 7.6% of the population, respectively.” Going forward, “researchers are calling for mental health [professionals] to routinely screen for cannabis use.” The study was published in The Canadian Journal of Psychiatry.

Related Links:

— “Study Links Rising Cannabis Use to Poor Mental Health,”Deanna Neff, HealthDay, March 5, 2026

MedPage Today (3/4, Firth) reports a study found that “disenrollment from health plans was associated with an increased risk of mortality among patients who initiated medications for opioid use disorder (OUD).” Researchers observed that “in adjusted analyses of more than 20,000 patients, ever experiencing disenrollment was associated with increased risks of all-cause mortality (HR 1.51) and overdose mortality (HR 1.56).” Furthermore, “the all-cause mortality rates were 17.6 versus 14.7 per 1,000 person-years for patients with and without health plan disenrollment, respectively, while rates of overdose mortality were 8.9 versus 5.4 per 1,000 person-years.” The study was published in JAMA Psychiatry.

Related Links:

— MedPage Today (requires login and subscription)

The AP (3/4, Aleccia) reports that “GLP-1 drugs…may help prevent multiple substance use disorders – and reduce the tragic outcomes they cause, a large new study finds.” Investigators “looked at electronic health records from more than 600,000 U.S. Veterans Affairs patients with diabetes.” The researchers “found that those treated with” GLP-1 “medications…were less likely to develop addictions to alcohol, nicotine, cocaine, opioids and other substances than those treated with a different class of drugs.” Among “those already addicted, the GLP-1 drugs were linked to lower risks of hospitalization, overdose and death, according to the study.” The findings were published in The BMJ.

Among other sources covering the story are Reuters (3/4, Lapid) and NBC News (3/4, Sullivan).

Related Links:

— “What to know about how GLP-1 medications might fight addiction,” Jonel Aleccia , AP , March 4, 2026